The Flowr Corporation (TSXV:FLWR)


The Flowr Corporation, earlier known as The Needle Capital Corp., is a healthcare company that operates in the drug manufacturing industry.
The Flowr Corporation is a public company listed on the Toronto Venture Stock Exchange in Canada, with its common shares trading under the ticker symbol FLWR. The cannabis company also lists and trades its common shares on the Over the Counter Market in the United States under the stock symbol FLWPF.
The Toronto-based company cultivates, manufactures, distributes and markets cannabis products for medical and recreation purposes.
The company offers cannabis products in different formats, including cannabis flowers and pre-rolls. It also aims for new formats, such as cannabis oils and edibles, vape technology, beverages and topical products.
Flowr Corporation believes that greenhouse and outdoor cultivated cannabis extracts infused in the new cannabinoid formats through its facilities would increase the demand for its new products.
The company markets cannabis products under three brand names:
• Flowr
• FlowrRX
• Holigen
The Kelowna 1 is the flagship indoor facility of the company. It covers a total land area of 85 thousand square feet with an optimal capacity to produce ten thousand kilograms of cannabis. This facility is licensed and operational, with 20 in-built controlled rooms to cultivate cannabis.
Flowr Forest is a licensed outdoor cultivation facility with 42 greenhouses over a total land area of 330 thousand square feet. It has a production capacity of ten thousand kilograms of cannabis, which are utilized for cannabis derivatives.
Hawthorne R&D Facility is contiguous to the K1 Facility. It is a 50 thousand square feet research and development facility held with Hawthorne Gardening Company under a strategic alliance.
The Flowr Corporation also operates cannabis cultivation facilities in Sintra and Aljustrel, Portugal (Europe) and Australia through Holigen Holdings Ltd, it's 100 percent owned subsidiary.
In August 2021, the company reported that RPK Biopharma Ltd (a subsidiary in which it indirectly holds a 100 percent interest) signed licensing agreements with Cookies Creative Consulting and Promotions Inc. According to the agreements, RPK would grow the Cookies products from its Sintra Facility and market them in Portugal to expand its operation within the European Union.

Contact Information

company address 60 Adelaide Street East Suite 1000 Toronto, Ontario M5C 3E4

company phone877 356-9726

company email[email protected]

company website

Similar Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK